Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.30
Delayed Data
As of 4:00pm ET
 +0.05 / +0.61%
Today’s Change
5.20
Today|||52-Week Range
9.32
+26.72%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.25
Today’s open8.29
Day’s range8.25 - 8.35
Volume4,579
Average volume (3 months)17,211
Market cap$184.0M
Dividend yield--
Data as of 4:00pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+19.07%
Revenue growth (last year)-5.35%
P/E ratio--
Price/Sales3.12
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
PIRSPieris Pharmaceutica...+0.31+7.49%
GNCAGenocea Biosciences ...-0.04-0.67%
VBIVVBI Vaccines Inc-0.08-1.88%
PTGXProtagonist Therapeu...-0.51-5.60%
Data as of 4:00pm ET, 05/25/2017

Financials

Last reporting dateMay 17, 2017
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Erez Israeli
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts